XML 37 R27.htm IDEA: XBRL DOCUMENT
v3.24.3

Earnings Per Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Earnings Per Share [Abstract] |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | Anti-dilutive stock awards were as follows for the periods presented:
| Quarter Ended September 30, |  | Nine Months Ended September 30,
(in thousands) | 2024 |  | 2023 |  | 2024 |  | 2023
Stock awards | 333 |  |  | 333 |  |  | 334 |  |  | 373 |
Total | 333 |  |  | 333 |  |  | 334 |  |  | 373 |
Basic And Diluted Earnings Per Share | The following table presents the earnings per share calculation for the periods presented:
|  | Quarter Ended September 30, |  | Nine Months Ended September 30,
|  | 2024 |  | 2023 |  | 2024 |  | 2023
Net Income (in millions) |  | $ | 912.8 |  |  | $ | 750.2 |  |  | $ | 2,651.2 |  |  | $ | 2,411.6 |
Less: preferred stock dividends |  | (5.3) |  |  | (5.0) |  |  | (15.8) |  |  | (15.1) |
Less: undistributed earnings allocated to preferred stock |  | (6.2) |  |  | (4.4) |  |  | (17.6) |  |  | (15.2) |
Net Income Attributable to Common Shareholders of CME Group |  | $ | 901.3 |  |  | $ | 740.8 |  |  | $ | 2,617.8 |  |  | $ | 2,381.3 |
Weighted Average Number of Common Shares (in thousands): |  |  |  |  |  |  |  |
Basic |  | 359,400 |  |  | 359,020 |  |  | 359,329 |  |  | 358,965 |
Effect of stock options, restricted stock and performance shares |  | 589 |  |  | 599 |  |  | 570 |  |  | 483 |
Diluted |  | 359,989 |  |  | 359,619 |  |  | 359,899 |  |  | 359,448 |
Earnings per Common Share Attributable to Common Shareholders of CME Group: |  |  |  |  |  |  |  |
Basic |  | $ | 2.51 |  |  | $ | 2.06 |  |  | $ | 7.29 |  |  | $ | 6.63 |
Diluted |  | 2.50 |  |  | 2.06 |  |  | 7.27 |  |  | 6.62 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration